ALLO
USDAllogene Therapeutics Inc. Common Stock
$1.138-0.022 (-1.897%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$1.160
High
$1.170
Low
$1.130
Volume
2.71M
Company Fundamentals
Market Cap
252.5M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
3.36M
Exchange
NMS
Currency
USD
52-Week Range
Low $0.86Current $1.138High $3.78
Related News
GlobeNewswire
Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (NASDAQ:ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™)
View more
GlobeNewswire
Allogene Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update
Conference Call and Webcast Scheduled for November 6, 2025 at 2:00 p.m. PT/5:00 p.m. ET SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (NASDAQ:ALLO), a clinical-stage
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.